Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Semin Oncol. 2015 Sep 8;43(1):173–188. doi: 10.1053/j.seminoncol.2015.09.011

Figure 1. HIV lifecycle and steps targeted by antiretroviral therapy.

Figure 1

Current agents target human immunodeficiency virus (HIV) cell surface interactions that inhibit HIV – entry, or target HIV-encoded enzymes that are required for reverse transcription, integration, or protease activity. CD4- cluster of differentiation 4; CXCR4- chemokine receptor type 4; chemokine receptor type 5